Senza® HFX iQ™ is the First and Only SCS System that Uses Artificial Intelligence to Optimize and Maintain Pain Relief Using Each Patient's Response REDWOOD CITY, Calif., March 7, 2023 /PRNewswire/ -- ...

HFX iQ is the first and only spinal cord stimulation (SCS) system integrating high-frequency SCS landmark evidence with cloud data insights, leading the way for personalized, data-driven patient care* ...

HFX AdaptivAI™ powering HFX iQ™, the only AI-enabled spinal cord stimulation system. Image courtesy of Nevro Corp. By Nevro Corp. . By Nevro Corp. HFX AdaptivAI combines insights from over 100,000 ...

Nevro yesterday announced that the FDA has granted approval for a study evaluating its high-frequency spinal cord stimulation system for the treatment of chronic pain. The device company’s Senza ...

US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord stimulation (SCS) system. The HFX iQ is an advanced SCS system designed to help ...

Experts in diabetes, pain and health services from the Worldwide Initiative for Diabetes Education recommend spinal cord stimulation when symptoms aren't responsive to first- or second-line therapies ...

HFX AdaptivAI combines insights from over 100,000 patients and more than 100 million data points¹ and leverages artificial intelligence (AI) to deliver responsive and personalized pain relief in real ...